- Home
- SNSE vs NCRA Comparison
SNSE vs NCRA Comparison
Compare SNSE & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNSE | NCRA |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9M | 12.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNSE | NCRA |
|---|---|---|
| Price | $9.75 | $0.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $72.50 | N/A |
| AVG Volume (30 Days) | ★ 88.4K | 52.6K |
| Earning Date | 11-14-2025 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,106,275.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.00 | $0.68 |
| 52 Week High | $18.35 | $2.40 |
Technical Indicators
Market Signals| Indicator | SNSE | NCRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 36.41 |
| Support Level | $9.32 | $0.82 |
| Resistance Level | $11.51 | $0.96 |
| Average True Range (ATR) | 1.06 | 0.10 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 33.33 | 0.00 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.